$TAYD
TAYLOR DEVICES, INC.

2023 Q3 Form 10-Q Financial Statement

#000137647423000443 Filed on September 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $9.924M $10.72M
YoY Change 9.16% 11.0%
Cost Of Revenue $5.539M $6.153M
YoY Change -2.92% -0.48%
Gross Profit $4.385M $4.567M
YoY Change 29.54% 31.44%
Gross Profit Margin 44.18% 42.6%
Selling, General & Admin $2.336M $2.282M
YoY Change 27.58% 33.52%
% of Gross Profit 53.28% 49.97%
Research & Development $129.1K $215.5K
YoY Change -65.61% -78.45%
% of Gross Profit 2.94% 4.72%
Depreciation & Amortization $455.5K $468.5K
YoY Change 43.33% 27.7%
% of Gross Profit 10.39% 10.26%
Operating Expenses $2.465M $2.497M
YoY Change 11.72% 46.12%
Operating Profit $1.920M $2.069M
YoY Change 62.9% 17.22%
Interest Expense $698.9K
YoY Change 15293.39%
% of Operating Profit 33.77%
Other Income/Expense, Net $361.3K -$435.6K
YoY Change 803.34% -13927.3%
Pretax Income $2.281M $2.333M
YoY Change 87.21% 31.56%
Income Tax $433.0K $266.0K
% Of Pretax Income 18.98% 11.4%
Net Earnings $1.848M $2.067M
YoY Change 84.35% 36.4%
Net Earnings / Revenue 18.62% 19.28%
Basic Earnings Per Share $0.52
Diluted Earnings Per Share $0.52 $0.56
COMMON SHARES
Basic Shares Outstanding 3.521M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.70M $28.09M
YoY Change 34.74% 18.95%
Cash & Equivalents $2.889M $3.575M
Short-Term Investments $27.81M $24.51M
Other Short-Term Assets $439.0K $228.9K
YoY Change 4.89% -67.5%
Inventory $6.830M $5.941M
Prepaid Expenses $439.6K
Receivables $5.400M $5.554M
Other Receivables $0.00 $0.00
Total Short-Term Assets $46.76M $44.38M
YoY Change 23.81% 16.85%
LONG-TERM ASSETS
Property, Plant & Equipment $11.69M $11.72M
YoY Change 12.76% 18.95%
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.810M $1.782M
YoY Change 41.17% 28.44%
Total Long-Term Assets $13.51M $13.50M
YoY Change 15.91% 20.12%
TOTAL ASSETS
Total Short-Term Assets $46.76M $44.38M
Total Long-Term Assets $13.51M $13.50M
Total Assets $60.27M $57.88M
YoY Change 21.95% 17.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.051M $1.718M
YoY Change -27.43% 20.38%
Accrued Expenses $2.463M $4.078M
YoY Change 22.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.327M $7.788M
YoY Change 62.3% 30.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.327M $7.788M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $8.330M $7.788M
YoY Change 62.35% 30.59%
SHAREHOLDERS EQUITY
Retained Earnings $43.98M $42.13M
YoY Change 19.36% 17.54%
Common Stock $11.07M $102.1K
YoY Change 6.79% -99.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.101M $3.085M
YoY Change 6.36% 5.82%
Treasury Stock Shares
Shareholders Equity $51.94M $50.09M
YoY Change
Total Liabilities & Shareholders Equity $60.27M $57.88M
YoY Change 21.95% 17.6%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $1.848M $2.067M
YoY Change 84.35% 36.4%
Depreciation, Depletion And Amortization $455.5K $468.5K
YoY Change 43.33% 27.7%
Cash From Operating Activities $3.038M $6.366M
YoY Change -9936.56% 117.98%
INVESTING ACTIVITIES
Capital Expenditures $427.7K $977.0K
YoY Change -48.69% -245.9%
Acquisitions
YoY Change
Other Investing Activities $1.128K -$5.239M
YoY Change -1.05% -49480.3%
Cash From Investing Activities -$3.727M -$6.216M
YoY Change 346.53% 843.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.883K 41.48K
YoY Change -91.83% 960.87%
NET CHANGE
Cash From Operating Activities $3.038M 6.366M
Cash From Investing Activities -$3.727M -6.216M
Cash From Financing Activities $2.883K 41.48K
Net Change In Cash -$685.8K 191.4K
YoY Change -20.77% -91.55%
FREE CASH FLOW
Cash From Operating Activities $3.038M $6.366M
Capital Expenditures $427.7K $977.0K
Free Cash Flow $2.610M $5.389M
YoY Change -402.02% 50.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-08-31
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
0-3498
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
TAYLOR DEVICES INC
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-0797789
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
90 Taylor Drive
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
North Tonawanda
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14120
CY2023Q3 dei Entity Address Address Description
EntityAddressAddressDescription
Address of principal executive offices
CY2023Q3 dei City Area Code
CityAreaCode
716
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
694-0800
CY2023Q3 dei Phone Fax Number Description
PhoneFaxNumberDescription
Registrant’s telephone number, including area code
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3521377 shares
CY2023Q3 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.025
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2889459 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3575219 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
27812740 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
24514757 usd
CY2023Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
5403750 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
5553504 usd
CY2023Q3 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
6830311 usd
CY2023Q2 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
5941304 usd
CY2023Q3 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
3388971 usd
CY2023Q2 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
4124182 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
439021 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
668554 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
46764252 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
44377520 usd
CY2023Q3 us-gaap Other Inventory Noncurrent
OtherInventoryNoncurrent
1032640 usd
CY2023Q2 us-gaap Other Inventory Noncurrent
OtherInventoryNoncurrent
1003140 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11693958 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11721784 usd
CY2023Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
211248 usd
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
210120 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
568615 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
568615 usd
CY2023Q3 us-gaap Assets
Assets
60270713 usd
CY2023Q2 us-gaap Assets
Assets
57881179 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1051457 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1717657 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2462747 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4078322 usd
CY2023Q3 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
4813033 usd
CY2023Q2 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
1992470 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8327237 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7788449 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11067898 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11049216 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43976119 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42128256 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3100541 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3084742 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
51943476 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
50092730 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60270713 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57881179 usd
CY2023Q3 us-gaap Revenues
Revenues
9923628 usd
CY2022Q3 us-gaap Revenues
Revenues
9090699 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5539052 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5598942 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
4384576 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
3491757 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
129074 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
375346 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2335957 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1938038 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1919545 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1178373 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
361318 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39998 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2280863 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1218371 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
433000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
216000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1847863 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1002371 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
51943476 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
44292816 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1847863 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1002371 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
455478 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
317790 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-149754 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1365612 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
918507 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-57869 usd
CY2023Q3 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-735211 usd
CY2022Q3 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-503936 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-229533 usd
CY2022Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-285883 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-666200 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
22114 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1615575 usd
CY2022Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1346571 usd
CY2023Q3 us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
2820563 usd
CY2022Q3 us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
491334 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3038120 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30886 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
427652 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
833464 usd
CY2023Q3 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
3297983 usd
CY2022Q3 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 usd
CY2023Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1128 usd
CY2022Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1140 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3726763 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-834604 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18682 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35291 usd
CY2023Q3 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
15799 usd
CY2022Q3 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2883 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35291 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-685760 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-830199 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3575219 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22517038 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2889459 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21686839 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3520910 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3499023 shares
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
854115 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
673453 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
5750443 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
5005416 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
286753 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
330435 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
6891311 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
6009304 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
61000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
68000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
6830311 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
5941304 usd
CY2023Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
367902 usd
CY2023Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
367902 usd
CY2023Q3 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
1403744 usd
CY2023Q2 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
3023501 usd
CY2023Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
691101 usd
CY2023Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
686919 usd
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2462747 usd
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4078322 usd

Files In Submission

Name View Source Status
0001376474-23-000443-index-headers.html Edgar Link pending
0001376474-23-000443-index.html Edgar Link pending
0001376474-23-000443.txt Edgar Link pending
0001376474-23-000443-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tayd-20230831.htm Edgar Link pending
tayd-20230831.xsd Edgar Link pending
td_ex31z1.htm Edgar Link pending
td_ex31z2.htm Edgar Link pending
td_ex32z1.htm Edgar Link pending
td_ex32z2.htm Edgar Link pending
tayd-20230831_def.xml Edgar Link unprocessable
tayd-20230831_cal.xml Edgar Link unprocessable
tayd-20230831_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
tayd-20230831_pre.xml Edgar Link unprocessable
tayd-20230831_htm.xml Edgar Link completed